# Effect of Tegoprazan or RAPA114 on Pharmacokinetic of Atorvastatin in Healthy Adult Volunteers

> **NCT04221321** · PHASE1 · COMPLETED · sponsor: **HK inno.N Corporation** · enrollment: 32 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Atorvastatin 40 mg
- **DRUG:** Tegoprazan 50 mg
- **DRUG:** RAPA114

## Key facts

- **NCT ID:** NCT04221321
- **Lead sponsor:** HK inno.N Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-07
- **Primary completion:** 2020-03-12
- **Final completion:** 2020-04-20
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2020-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04221321

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04221321, "Effect of Tegoprazan or RAPA114 on Pharmacokinetic of Atorvastatin in Healthy Adult Volunteers". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04221321. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*